A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer.

Autor: Zhou, Qing, Gustafson, Daniel, Nallapareddy, Sujatha, Diab, Sami, Leong, Stephen, Lewis, Karl, Gore, Lia, Messersmith, Wells, Treston, Anthony, Eckhardt, S., Sidor, Carolyn, Camidge, D.
Zdroj: Investigational New Drugs; Apr2011, Vol. 29 Issue 2, p340-346, 7p
Databáze: Complementary Index
Externí odkaz: